Century Therapeutics, Inc. (IPSC) NASDAQ
2.17
-0.19(-8.05%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.17
-0.19(-8.05%)
Currency In USD
| Market Cap | 86.11M |
| Enterprise Value | 67.82M |
| P/E Ratio | -1.74 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.71 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.86 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.33 |
| Return On Equity | -0.53 |
| Revenue | 109.16M |
| Revenue/Share | 0 |
| Gross Profit | 96.06M |
| EBITDA | -1.94M |
| Net Income | -9.58M |
| Diluted EPS | -0.11 |
| Total Cash | 134.8M |
| Total Cash/Share | 1.56 |
| Total Debt | 43.94M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 10.25 |
| Book Value Per Share | 3.06 |
| 52-Week Change | 299.26 |
| 52-Week High | 3.04 |
| 52-Week Low | 0.44 |
| Moving Average 50 Days | 2.28 |
| Moving Average 200 Days | 1.4 |
| Average Volume | 1.2M |
| Shares Outstanding | 86.57M |
| % Held by Institutions | 158.68 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |